Geneva Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.18M Buy
35,798
+5,510
+18% +$182K 0.02% 329
2017
Q1
$999K Buy
30,288
+5,467
+22% +$176K 0.02% 356
2016
Q4
$776K Buy
24,821
+2,623
+12% +$81K 0.02% 403
2016
Q3
$787K Buy
22,198
+3,437
+18% +$122K 0.01% 374
2016
Q2
$637K Buy
18,761
+2,588
+16% +$86.4K 0.01% 394
2016
Q1
$571K Buy
16,173
+270
+2% +$8.84K 0.01% 405
2015
Q4
$556K Buy
+15,903
New +$549K 0.01% 397

Other funds holding OHI

Geneva Advisors's OHI Position: Q2 2017 in Review

Geneva Advisors increased its Omega Healthcare (OHI) stake by 18% in Q2 2017, buying an estimated $182K and bringing the position to 35,798 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #329.

Geneva Advisors first reported a position in OHI in Q4 2015 and has held it in 7 quarters since. 427 funds tracked by Wall St. Rank hold OHI as of Q2 2017.

  • Geneva Advisors held 35,798 shares of Omega Healthcare worth $1.18M as of Q2 2017.
  • Geneva Advisors bought 5,510 Omega Healthcare shares in Q2 2017, an estimated $182K.
  • Omega Healthcare made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #329 holding.
  • Geneva Advisors first reported a position in Omega Healthcare in Q4 2015 and has held it in 7 quarters since.
  • 427 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.